Cullinan Therapeutics, Inc. (CGEM)
NASDAQ: CGEM · Real-Time Price · USD
12.81
-0.44 (-3.32%)
At close: Apr 28, 2026, 4:00 PM EDT
12.98
+0.17 (1.33%)
After-hours: Apr 28, 2026, 4:46 PM EDT
Cullinan Therapeutics Employees
Cullinan Therapeutics had 109 employees as of December 31, 2025. The number of employees decreased by 2 or -1.80% compared to the previous year.
Employees
109
Change (1Y)
-2
Growth (1Y)
-1.80%
Revenue / Employee
n/a
Profits / Employee
-$2,017,239
Market Cap
775.34M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Kura Oncology | 260 |
| ARS Pharmaceuticals | 163 |
| Allogene Therapeutics | 152 |
| Absci | 140 |
| Solid Biosciences | 121 |
| Vor Biopharma | 76 |
| Design Therapeutics | 54 |
| Crescent Biopharma | 44 |
CGEM News
- 10 hours ago - U.S. Food and Drug Administration Accepts New Drug Application for Zipalertinib for the Treatment of Locally Advanced or Metastatic Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations - Business Wire
- 7 weeks ago - Cullinan Therapeutics Transcript: Leerink Global Healthcare Conference 2026 - Transcripts
- 7 weeks ago - Cullinan Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2025 Financial Results - GlobeNewsWire
- 2 months ago - Cullinan Therapeutics Transcript: TD Cowen 46th Annual Health Care Conference - Transcripts
- 2 months ago - Cullinan Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - Cullinan Therapeutics Transcript: Citi’s 2026 Virtual Oncology Leadership Summit - Transcripts
- 2 months ago - Cullinan Therapeutics to Participate in Fireside Chat at the Citi 2026 Virtual Oncology Leadership Summit - GlobeNewsWire
- 2 months ago - Cullinan Therapeutics Transcript: Guggenheim Securities Emerging Outlook: Biotech Summit 2026 - Transcripts